|Application ||WB, E|
|Other Accession||O89032, NP_055446.2|
|Calculated MW||125289 Da|
|Antigen Region||222-250 aa|
|Other Names||SH3 and PX domain-containing protein 2A, Adapter protein TKS5, Five SH3 domain-containing protein, SH3 multiple domains protein 1, Tyrosine kinase substrate with five SH3 domains, SH3PXD2A, FISH, KIAA0418, SH3MD1, TKS5|
|Target/Specificity||This SH3PXD2A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 222-250 amino acids from the N-terminal region of human SH3PXD2A.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||SH3PXD2A Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Synonyms||FISH, KIAA0418, SH3MD1, TKS5|
|Function||Adapter protein involved in invadopodia and podosome formation, extracellular matrix degradation and invasiveness of some cancer cells. Binds matrix metalloproteinases (ADAMs), NADPH oxidases (NOXs) and phosphoinositides. Acts as an organizer protein that allows NOX1- or NOX3-dependent reactive oxygen species (ROS) generation and ROS localization. In association with ADAM12, mediates the neurotoxic effect of beta-amyloid peptide.|
|Cellular Location||Cytoplasm. Cell projection, podosome. Note=Cytoplasmic in normal cells and localizes to podosomes in SRC-transformed cells|
|Tissue Location||Found in several cancer cell lines, particularly invasive breast carcinomas and melanomas|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
SH3PXD2A is required for podosome formation, degradation of the extracellular matrix, and for the invasiveness of some cancer cells. Binds phosphatidylinositol 3-phosphate (PtdIns(3)P) and phosphatidylinositol 3,4-biphosphate (PtdIns(3,4)P2). In association with ADAM12, mediates the neurotoxic effect of beta-amyloid peptide.
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :
Laumet, G., et al. Neurosci. Lett. 468(1):1-2(2010)
Crimaldi, L., et al. Exp. Cell Res. 315(15):2581-2592(2009)
Voss, M., et al. BMC Immunol. 10, 53 (2009) :
Gianni, D., et al. Sci Signal 2 (88), RA54 (2009) :
If you have any additional inquiries please email technical services at firstname.lastname@example.org.